Scott Hoffmann is a Senior Scientist at Roche since September 2025, following a tenure at AstraZeneca where Scott held the titles of Associate Director and Senior Scientist from October 2020 to October 2025. Prior experience includes serving as a PhD student at The University of Edinburgh from September 2015 to October 2020 and a summer intern at AstraZeneca in 2018, focusing on drug safety and metabolism within the Mass Spectrometry Imaging Team. Scott Hoffmann earned a Doctor of Philosophy in Biomedical Imaging/Cardiovascular Sciences and a Master of Science by Research in Biomedical Sciences from The University of Edinburgh, as well as a Bachelor of Science in Biology from the University of Dundee.
This person is not in any offices